Abiopharma

New Form S-3 - Jade Biosciences, Inc. <b>Filed:</b> 2026-05-07 <b>AccNo:</b> 0001193125-26-212443 <b>Size:</b> 514 KB

New Form 424B2 - NOMURA HOLDINGS INC <b>Filed:</b> 2026-05-07 <b>AccNo:</b> 0001104659-26-057292 <b>Size:</b> 1 MB

New Form S-8 POS - IN8BIO, INC. <b>Filed:</b> 2026-05-07 <b>AccNo:</b> 0001193125-26-212441 <b>Size:</b> 66 KB

The company’s liability balance as of March 31, 2026, by maturity dates

New Form FWP - V2X, Inc. <b>Filed:</b> 2026-05-07 <b>AccNo:</b> 0001104659-26-057290 <b>Size:</b> 11 KB

New Form SCHEDULE 13G - Fortress Value Acquisition Corp. V <b>Filed:</b> 2026-05-07 <b>AccNo:</b> 0001213900-26-053423 <b>Size:</b> 14 KB

New Form S-8 - IN8BIO, INC. <b>Filed:</b> 2026-05-07 <b>AccNo:</b> 0001193125-26-212434 <b>Size:</b> 222 KB

New Form S-8 - Edgewise Therapeutics, Inc. <b>Filed:</b> 2026-05-07 <b>AccNo:</b> 0001104659-26-057287 <b>Size:</b> 253 KB

New Form SCHEDULE 13G/A - DIEBOLD NIXDORF, Inc <b>Filed:</b> 2026-05-07 <b>AccNo:</b> 0001644956-26-000016 <b>Size:</b> 6 KB

Deadline Approaching: FS KKR Capital Corp. (FSK) Shareholders Who Lost Money Urged to Contact Law Offices of Howard G. Smith

New Form SCHEDULE 13G - Cartesian Growth Corp III <b>Filed:</b> 2026-05-07 <b>AccNo:</b> 0001104659-26-057286 <b>Size:</b> 15 KB

New Form 8-K/A - Johnson Controls International plc <b>Filed:</b> 2026-05-07 <b>AccNo:</b> 0000833444-26-000054 <b>Size:</b> 1 MB <br />Item 2.02: Results of Operations and Financial Condition <br />Item 9.01: Financial Statements and Exhibits

New Form S-3 - Jade Biosciences, Inc. <b>Filed:</b> 2026-05-07 <b>AccNo:</b> 0001193125-26-212422 <b>Size:</b> 1 MB

New Form 8-K/A - Cloudflare, Inc. <b>Filed:</b> 2026-05-07 <b>AccNo:</b> 0001477333-26-000035 <b>Size:</b> 543 KB <br />Item 2.02: Results of Operations and Financial Condition <br />Item 2.05: Cost Associated with Exit or Disposal Activities <br />Item 7.01: Regulation FD Disclosure <br />Item 9.01: Financial Statements and Exhibits

Q1 2026 report